Back to Search
Start Over
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors.
- Source :
- Journal of Clinical Oncology; 12/1/2016, Vol. 34 Issue 34, Following p4142-4150, 9p, 1 Color Photograph, 4 Charts, 1 Graph
- Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 34
- Issue :
- 34
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 119580242
- Full Text :
- https://doi.org/10.1200/JCO.2015.65.3949